Cholamandalam Investment & Finance Upgraded to Buy on Strong Fundamentals and Technical Signals

Technical Trends Shift to Mildly Bullish

The primary catalyst for the rating upgrade stems from a recalibration of Cholamandalam’s technical grade, which has shifted from bullish to mildly bullish. While the weekly Moving Average Convergence Divergence (MACD) remains bullish, the monthly MACD has softened to mildly bearish, signalling some caution in longer-term momentum. The Relative Strength Index (RSI) on a weekly basis has turned bearish, though the monthly RSI remains neutral, indicating a mixed momentum picture.

Bollinger Bands on both weekly and monthly charts show mild bullishness, suggesting moderate upward price volatility. Daily moving averages continue to support a bullish stance, reinforcing short-term positive momentum. The Know Sure Thing (KST) indicator is bullish weekly but mildly bearish monthly, while Dow Theory analysis reveals no clear weekly trend but a bullish monthly outlook. On-Balance Volume (OBV) is neutral weekly and mildly bullish monthly, reflecting cautious accumulation by investors.

Overall, these technical signals suggest that while short-term momentum is positive, longer-term trends warrant close monitoring. The downgrade in some monthly indicators tempers enthusiasm but does not negate the prevailing bullish sentiment, justifying the upgrade to a Buy rating from a technical perspective.

Valuation Adjusted from Very Expensive to Expensive

Cholamandalam’s valuation grade has been revised from very expensive to expensive, reflecting a slight moderation in price multiples relative to earnings and book value. The company currently trades at a price-to-earnings (PE) ratio of 29.04, which, while high, is more reasonable compared to peers such as Bajaj Finance (PE 34.47) and ICICI AMC (PE 44.11). The price-to-book (P/B) ratio stands at 4.99, indicating a premium valuation but still within a range that investors are willing to pay for quality NBFCs.

Enterprise value to EBITDA (EV/EBITDA) is 16.45, and the PEG ratio is 1.38, suggesting that earnings growth is somewhat priced in but not excessively so. Return on capital employed (ROCE) at 9.21% and return on equity (ROE) at 17.18% underpin the company’s ability to generate returns on invested capital, justifying the premium valuation to an extent. Dividend yield remains low at 0.11%, consistent with growth-oriented NBFCs reinvesting earnings for expansion.

Compared to peers, Cholamandalam’s valuation is expensive but not out of line with the sector’s top performers, supporting the upgrade while signalling that investors should remain mindful of valuation risks.

Robust Financial Trends Support Positive Outlook

Financially, Cholamandalam has demonstrated strong performance in the latest quarter (Q4 FY25-26), with net sales reaching a record ₹8,416.71 crores and PBDIT hitting ₹5,819.81 crores. Cash and cash equivalents also surged to ₹14,695.08 crores in the half-year period, highlighting solid liquidity. Operating profit has grown at an annualised rate of 26.38%, reflecting operational efficiency and market demand.

The company’s average ROE of 17.90% over the long term underscores its ability to generate shareholder value consistently. Institutional investors hold a significant 44.79% stake, having increased their holdings by 0.68% in the previous quarter, signalling confidence from sophisticated market participants.

Cholamandalam’s stock has outperformed the Sensex and BSE500 indices over multiple time horizons, delivering 14.37% returns in the past year against the Sensex’s -4.95%, and an impressive 262.94% over five years compared to the Sensex’s 48.87%. This market-beating performance reinforces the company’s strong fundamentals and growth trajectory.

Quality Assessment Remains Strong

Cholamandalam’s overall quality, as reflected in its Mojo Score of 72.0 and a Mojo Grade upgrade to Buy from Hold, indicates a solid investment proposition. The company is classified as a large-cap NBFC with a well-established market presence and a track record of consistent earnings growth. Its financial discipline, evidenced by strong ROE and ROCE figures, supports sustainable profitability.

Institutional backing further enhances the company’s quality profile, as these investors typically conduct rigorous due diligence before increasing stakes. The company’s ability to maintain healthy operating margins and generate cash flow adds to its investment appeal.

Risks and Considerations

Despite the positive outlook, investors should be mindful of certain risks. The stock’s valuation remains on the expensive side, with a P/B ratio near 5 and a PEG ratio of 1.38, indicating that growth expectations are largely priced in. The recent one-week price decline of 1.48% contrasts with a modest Sensex gain of 0.12%, suggesting some short-term volatility.

Moreover, while the company’s profits have risen by 22.8% over the past year, the premium valuation means that any slowdown in earnings growth could pressure the stock price. Technical indicators also show mixed signals, with some monthly metrics turning bearish, warranting cautious monitoring.

Overall, the upgrade to Buy reflects a balanced view that acknowledges both the company’s strengths and the valuation premium it commands.

Conclusion

The upgrade of Cholamandalam Investment & Finance Company Ltd’s rating to Buy is underpinned by a combination of improved technical signals, a more reasonable valuation stance, robust financial trends, and strong quality metrics. While valuation remains a concern, the company’s consistent earnings growth, market-beating returns, and institutional support provide a compelling case for investors seeking exposure to the NBFC sector.

Investors should continue to monitor technical indicators and valuation multiples closely, but the current outlook suggests that Cholamandalam is well-positioned to deliver sustained value in the medium to long term.

Get 33% Off on our 1 Year Plan - Limited Period Only! Start Today